Kevin W. Hunt

Iodine(V) Reagents in Organic Synthesis. Part 3. New Routes to Heterocyclic Compounds via <i>o</i>-Iodoxybenzoic Acid-Mediated Cyclizations:  Generality, Scope, and Mechanism

K. C. Nicolaou, Phil S. Baran, Yong‐Li Zhong et al. · Journal of the American Chemical Society · 2002 · 262 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Effects of a ketamine metabolite on synaptic NMDAR function

Kanzo Suzuki, E. D. Nosyreva, Kevin W. Hunt et al. · Nature · 2017 · 175 citations

Life Sciences, Neurobiology, Neuroscience +14

Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species

Kevin W. Hunt, Adam W. Cook, Ryan J. Watts et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Selective Synthesis of 1-Functionalized-alkyl-1<i>H</i>-indazoles

Kevin W. Hunt, David A. Moreno, Nicole Suiter et al. · Organic Letters · 2009 · 57 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

Model Studies Towards Azadirachtin: Part 1. Construction of the Crowded C8bC14 Bond by Radical Chemistry We thank Drs. D. H. Huang and G. Siuzdak for NMR spectroscopic and mass spectrometric assistance, respectively. This work was financially supported by the National Institutes of Health (USA), the Skaggs Institute for Chemical Biology, postdoctoral fellowships from Bayer AG (to M.F.) and the G. E. Hewitt Foundation (to K.W.H.), a predoctoral fellowship from the Division of Organic Chemistry of the American Chemical Society sponsored by Novartis (to A.J.R.), and grants from Abbott Laboratories, ArrayBiopharma, Bayer, Boehringer Ingelheim, DuPont, Glaxo, Hoffmann-LaRoche, Merck, Novartis, Pfizer, and Schering Plough.

K. C. Nicolaou, Markus Follmann, A. J. Roecker et al. · Angewandte Chemie International Edition · 2002 · 43 citations

Natural Sciences, Biochemistry, Chemistry +5